11 results · 28ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

ACTISORB SILVER 220 ANTIMICROBIAL BINDING DRESSING

FDA 510(k)
FDA Unclassified ·Unknown

INSTANT-VIEW Pregnancy Combo Cassette Test

FDA UDI
ALFA SCIENTIFIC DESIGNS, INC.·10796918000030·INSTANT-VIEW HCG Combo Cassette Test

POWER 5000 GENERAL PURPOSE COIL

FDA 510(k)
FDA Class 2 ·Radiology

AMEDITECH IMMUTEST DRUG SCREEN OPIATES

FDA 510(k)
FDA Class 2 ·Clinical Toxicology

PYXIS MEDSTATION ES SYSTEM

FDA Adverse Event
Malfunction ·CAREFUSION 303·Product code BRY·March 7, 2025

PENUMBRA SMART COIL

FDA Adverse Event
Malfunction ·PENUMBRA, INC.·Product code HCG·December 19, 2017

PELVISOFT ACELLULAR COLLAGEN BIOMESH

FDA Adverse Event
Injury ·TISSUE SCIENCE LABORATORIES·Product code FTM·March 20, 2013

SM104 MSERIES W/5TH WHL

FDA Adverse Event
Malfunction ·STRYKER MEDICAL·Product code FPO·February 15, 2011

LUPINE DRILL GUIDE

FDA Adverse Event
Malfunction ·DEPUY MITEK·Product code HRX·March 31, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024